<DOC>
	<DOCNO>NCT01298973</DOCNO>
	<brief_summary>The purpose study look ability Viscoat ensure proper wound closure .</brief_summary>
	<brief_title>Dispervise Ophthalmic Viscoelastic Agent Ensure Watertight Wound Closure After Clear Corneal Cataract Incisions</brief_title>
	<detailed_description />
	<mesh_term>Cataract</mesh_term>
	<criteria>Ability provide inform consent , complete questionnaire , likely complete visit Subject must male female , race , least 21 year old Undergoing uncomplicated cataract surgery clear corneal incision Subjects known sensitivity inappropriate responsiveness medication use postoperative course Acute chronic disease illness would increase risk confound study result ( e.g. , uncontrolled diabetes mellitus , immunocompromised , etc . ) Uncontrolled systemic disease Corneal abnormality ( e.g. , stromal , epithelial endothelial dystrophy ) Subjects use concurrent topical systemic medication may impair heal , include limited : antimetabolite , isotretinoin ( Accutane ) within 6 month treatment , amiodarone hydrochloride ( Cordarone ) within 12 month treatment Subjects history follow medical condition , condition could affect wound healing : collagen vascular disease , autoimmune disease , immunodeficiency disease , ocular herpes zoster simplex , endocrine disorder ( include limit unstable thyroid disorder diabetes ) , lupus , rheumatoid arthritis Concurrent participation participation last 30 day clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
</DOC>